- Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients
-
Suh SW, Lee KW, Jeong J, Kim H, Yi NJ, Suh KS
- KMID: 2470265
- J Korean Med Sci.
- 2016 Nov;31(11):1711-1716.
- doi: 10.3346/jkms.2016.31.11.1711
Despite the therapeutic equivalence between twice-daily and once-daily tacrolimus, patient safety after conversion is still a concern. We reviewed 218 liver transplantation (LT) patients who converted twice-daily to once-daily tacrolimus... -
- CITED
-
- Close
- SHARE
-
- Close
